Analysts Set bluebird bio, Inc. (NASDAQ:BLUE) PT at $44.14
bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) has earned an average recommendation of “Hold” from the nine analysts that are covering the company, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year price objective among brokers that […]
bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) has earned an average recommendation of “Hold” from the nine analysts that are covering the company, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year price objective among brokers that […]
